ModivCare Net Worth
ModivCare Net Worth Breakdown | MODV |
ModivCare Net Worth Analysis
ModivCare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ModivCare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ModivCare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ModivCare's net worth analysis. One common approach is to calculate ModivCare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ModivCare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ModivCare's net worth. This approach calculates the present value of ModivCare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ModivCare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ModivCare's net worth. This involves comparing ModivCare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ModivCare's net worth relative to its peers.
Enterprise Value |
|
To determine if ModivCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ModivCare's net worth research are outlined below:
| ModivCare is way too risky over 90 days horizon | |
| ModivCare appears to be risky and price may revert if volatility continues | |
| ModivCare currently holds 1.3 B in liabilities with Debt to Equity (D/E) ratio of 2.88, implying the company greatly relies on financing operations through barrowing. ModivCare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ModivCare's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.79 B. Net Loss for the year was (201.28 M) with profit before overhead, payroll, taxes, and interest of 417.15 M. | |
| ModivCare currently holds about 72.7 M in cash with (6.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ModivCare has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of ModivCare shares are owned by institutional investors | |
| Latest headline from prnewswire.com: The Bahamas Grid Company publica los primeros resultados asociados con su mejora de 130 millones de dlares de la red elctrica de New Providence |
ModivCare Quarterly Good Will |
|
ModivCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ModivCare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ModivCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
ModivCare Target Price Consensus
ModivCare target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ModivCare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Buy |
Most ModivCare analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ModivCare stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ModivCare, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationModivCare Target Price Projection
ModivCare's current and average target prices are 3.00 and 5.94, respectively. The current price of ModivCare is the price at which ModivCare is currently trading. On the other hand, ModivCare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On ModivCare Target Price
Know ModivCare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ModivCare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ModivCare backward and forwards among themselves. ModivCare's institutional investor refers to the entity that pools money to purchase ModivCare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2025-03-31 | 236.2 K | Aqr Capital Management Llc | 2025-03-31 | 233 K | Renaissance Technologies Corp | 2025-03-31 | 201.7 K | Goldman Sachs Group Inc | 2025-03-31 | 171.4 K | Bank Of America Corp | 2025-03-31 | 169.7 K | Marshall Wace Asset Management Ltd | 2025-03-31 | 165.4 K | Wolverine Asset Management Llc | 2025-03-31 | 130.2 K | Bnp Paribas Arbitrage, Sa | 2025-03-31 | 108.7 K | Northern Trust Corp | 2025-03-31 | 103.1 K | Coliseum Capital Management Llc | 2025-03-31 | 4.5 M | Neuberger Berman Group Llc | 2025-03-31 | 2 M |
Follow ModivCare's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 43.06 M.Market Cap |
|
Project ModivCare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.29) | (0.28) | |
| Return On Capital Employed | (0.09) | (0.09) | |
| Return On Assets | (0.12) | (0.12) | |
| Return On Equity | 5.23 | 5.49 |
When accessing ModivCare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ModivCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ModivCare's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in ModivCare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ModivCare. Check ModivCare's Beneish M Score to see the likelihood of ModivCare's management manipulating its earnings.
Evaluate ModivCare's management efficiency
Return On Equity is likely to climb to 5.49 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.28). At this time, ModivCare's Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 51.9 M in 2025, whereas Total Current Assets are likely to drop slightly above 250.2 M in 2025. ModivCare's management efficiency ratios could be used to measure how well ModivCare manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (2.70) | (2.57) | |
| Tangible Book Value Per Share | (70.30) | (66.79) | |
| Enterprise Value Over EBITDA | 278.27 | 292.18 | |
| Price Book Value Ratio | (4.38) | (4.16) | |
| Enterprise Value Multiple | 278.27 | 292.18 | |
| Price Fair Value | (4.38) | (4.16) | |
| Enterprise Value | 1.4 B | 1.4 B |
Management at ModivCare focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Enterprise Value Revenue 0.4822 | Revenue | Quarterly Revenue Growth (0.05) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ModivCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on ModivCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ModivCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ModivCare time-series forecasting models is one of many ModivCare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ModivCare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ModivCare Earnings Estimation Breakdown
The calculation of ModivCare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ModivCare is estimated to be -0.69715 with the future projection ranging from a low of -1.0525 to a high of -0.271425. Please be aware that this consensus of annual earnings estimates for ModivCare is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.05 Lowest | Expected EPS | -0.27 Highest |
ModivCare Earnings Projection Consensus
Suppose the current estimates of ModivCare's value are higher than the current market price of the ModivCare stock. In this case, investors may conclude that ModivCare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ModivCare's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 3 | 68.03% | 0.0 | -0.69715 | -16.09 |
ModivCare Earnings per Share Projection vs Actual
Actual Earning per Share of ModivCare refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ModivCare predict the company's earnings will be in the future. The higher the earnings per share of ModivCare, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ModivCare Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ModivCare, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ModivCare should always be considered in relation to other companies to make a more educated investment decision.ModivCare Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ModivCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-04-30 | 2025-03-31 | -0.45 | -1.71 | -1.26 | 280 | ||
2025-02-20 | 2024-12-31 | 0.1749 | 0.19 | 0.0151 | 8 | ||
2024-11-06 | 2024-09-30 | 0.77 | 0.45 | -0.32 | 41 | ||
2024-08-07 | 2024-06-30 | 0.77 | -0.03 | -0.8 | 103 | ||
2024-05-02 | 2024-03-31 | 0.19 | -0.09 | -0.28 | 147 | ||
2024-02-22 | 2023-12-31 | 1.28 | 1.29 | 0.01 | 0 | ||
2023-11-02 | 2023-09-30 | 1.11 | 1.44 | 0.33 | 29 | ||
2023-08-03 | 2023-06-30 | 1.62 | 1.47 | -0.15 | 9 | ||
2023-05-04 | 2023-03-31 | 1.5 | 1.42 | -0.08 | 5 | ||
2023-02-23 | 2022-12-31 | 1.56 | 2.11 | 0.55 | 35 | ||
2022-11-03 | 2022-09-30 | 1.62 | 1.61 | -0.01 | 0 | ||
2022-08-04 | 2022-06-30 | 1.42 | 1.99 | 0.57 | 40 | ||
2022-05-05 | 2022-03-31 | 1.43 | 1.57 | 0.14 | 9 | ||
2022-02-25 | 2021-12-31 | 1.62 | 2.11 | 0.49 | 30 | ||
2021-11-05 | 2021-09-30 | 1.42 | 1.63 | 0.21 | 14 | ||
2021-08-06 | 2021-06-30 | 1.29 | 2.13 | 0.84 | 65 | ||
2021-05-07 | 2021-03-31 | 1.6 | 1.92 | 0.32 | 20 | ||
2021-02-26 | 2020-12-31 | 1.52 | 0.98 | -0.54 | 35 | ||
2020-11-06 | 2020-09-30 | 1.42 | 2.69 | 1.27 | 89 | ||
2020-08-06 | 2020-06-30 | 0.38 | 2.53 | 2.15 | 565 | ||
2020-05-07 | 2020-03-31 | 0.28 | 0.58 | 0.3 | 107 | ||
2020-02-27 | 2019-12-31 | 0.05 | 0.45 | 0.4 | 800 | ||
2019-11-06 | 2019-09-30 | 0.46 | 0.81 | 0.35 | 76 | ||
2019-08-07 | 2019-06-30 | 0.2 | 0.07 | -0.13 | 65 | ||
2019-05-08 | 2019-03-31 | 0.35 | 0.37 | 0.02 | 5 | ||
2019-02-28 | 2018-12-31 | 0.53 | 1.08 | 0.55 | 103 | ||
2018-11-07 | 2018-09-30 | 0.33 | 0.63 | 0.3 | 90 | ||
2018-08-07 | 2018-06-30 | 0.05 | 0.13 | 0.08 | 160 | ||
2018-05-09 | 2018-03-31 | 0.45 | 0.63 | 0.18 | 40 | ||
2018-03-08 | 2017-12-31 | 0.42 | 0.66 | 0.24 | 57 | ||
2017-11-07 | 2017-09-30 | 0.31 | 0.32 | 0.01 | 3 | ||
2017-08-08 | 2017-06-30 | 0.17 | 0.32 | 0.15 | 88 | ||
2017-05-09 | 2017-03-31 | 0.28 | 0.35 | 0.07 | 25 | ||
2017-03-09 | 2016-12-31 | 0.45 | 0.33 | -0.12 | 26 | ||
2016-11-08 | 2016-09-30 | 0.45 | 0.35 | -0.1 | 22 | ||
2016-08-01 | 2016-06-30 | 0.65 | 0.7 | 0.05 | 7 | ||
2016-05-05 | 2016-03-31 | 0.4 | 0.48 | 0.08 | 20 | ||
2016-03-10 | 2015-12-31 | 0.28 | 0.48 | 0.2 | 71 | ||
2015-11-09 | 2015-09-30 | 0.22 | 0.07 | -0.15 | 68 | ||
2015-08-06 | 2015-06-30 | 0.25 | 0.67 | 0.42 | 168 | ||
2015-05-11 | 2015-03-31 | 0.38 | 0.77 | 0.39 | 102 | ||
2015-03-16 | 2014-12-31 | 0.29 | 0.15 | -0.14 | 48 | ||
2014-11-05 | 2014-09-30 | 0.46 | 0.02 | -0.44 | 95 | ||
2014-08-06 | 2014-06-30 | 0.43 | 0.46 | 0.03 | 6 | ||
2014-05-07 | 2014-03-31 | 0.43 | 0.5 | 0.07 | 16 | ||
2014-03-12 | 2013-12-31 | 0.34 | 0.3 | -0.04 | 11 | ||
2013-11-06 | 2013-09-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2013-08-07 | 2013-06-30 | 0.34 | 0.43 | 0.09 | 26 | ||
2013-05-08 | 2013-03-31 | 0.32 | 0.49 | 0.17 | 53 | ||
2013-03-13 | 2012-12-31 | 0.24 | 0.22 | -0.02 | 8 | ||
2012-11-07 | 2012-09-30 | 0.15 | 0.16 | 0.01 | 6 | ||
2012-08-08 | 2012-06-30 | 0.17 | 0.11 | -0.06 | 35 | ||
2012-05-09 | 2012-03-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2012-03-14 | 2011-12-31 | 0.23 | 0.27 | 0.04 | 17 | ||
2011-11-02 | 2011-09-30 | 0.21 | 0.15 | -0.06 | 28 | ||
2011-08-08 | 2011-06-30 | 0.35 | 0.36 | 0.01 | 2 | ||
2011-05-04 | 2011-03-31 | 0.47 | 0.45 | -0.02 | 4 | ||
2011-03-09 | 2010-12-31 | 0.34 | 0.33 | -0.01 | 2 | ||
2010-11-03 | 2010-09-30 | 0.17 | 0.22 | 0.05 | 29 | ||
2010-08-04 | 2010-06-30 | 0.37 | 0.54 | 0.17 | 45 | ||
2010-05-05 | 2010-03-31 | 0.46 | 0.66 | 0.2 | 43 | ||
2010-03-10 | 2009-12-31 | 0.36 | 0.42 | 0.06 | 16 | ||
2009-11-04 | 2009-09-30 | 0.21 | 0.23 | 0.02 | 9 | ||
2009-08-10 | 2009-06-30 | 0.39 | 0.4 | 0.01 | 2 | ||
2009-05-06 | 2009-03-31 | 0.3 | 0.44 | 0.14 | 46 | ||
2009-03-27 | 2008-12-31 | 0.09 | -0.1 | -0.19 | 211 | ||
2008-11-05 | 2008-09-30 | -0.01 | -0.09 | -0.08 | 800 | ||
2008-08-06 | 2008-06-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2008-05-07 | 2008-03-31 | 0.3 | 0.29 | -0.01 | 3 | ||
2008-03-12 | 2007-12-31 | 0.34 | 0.35 | 0.01 | 2 | ||
2007-11-06 | 2007-09-30 | 0.27 | 0.27 | 0.0 | 0 | ||
2007-08-08 | 2007-06-30 | 0.29 | 0.3 | 0.01 | 3 | ||
2007-05-08 | 2007-03-31 | 0.26 | 0.28 | 0.02 | 7 | ||
2007-03-14 | 2006-12-31 | 0.19 | 0.26 | 0.07 | 36 | ||
2006-11-08 | 2006-09-30 | 0.3 | 0.22 | -0.08 | 26 | ||
2006-08-09 | 2006-06-30 | 0.29 | 0.28 | -0.01 | 3 | ||
2006-05-10 | 2006-03-31 | 0.24 | 0.26 | 0.02 | 8 | ||
2006-03-15 | 2005-12-31 | 0.23 | 0.24 | 0.01 | 4 | ||
2005-11-07 | 2005-09-30 | 0.27 | 0.26 | -0.01 | 3 | ||
2005-08-09 | 2005-06-30 | 0.23 | 0.24 | 0.01 | 4 | ||
2005-05-04 | 2005-03-31 | 0.21 | 0.22 | 0.01 | 4 | ||
2005-03-14 | 2004-12-31 | 0.24 | 0.25 | 0.01 | 4 | ||
2004-11-08 | 2004-09-30 | 0.2 | 0.22 | 0.02 | 10 | ||
2004-08-04 | 2004-06-30 | 0.16 | 0.15 | -0.01 | 6 | ||
2004-05-05 | 2004-03-31 | 0.13 | 0.13 | 0.0 | 0 | ||
2004-03-03 | 2003-12-31 | 0.13 | 0.13 | 0.0 | 0 | ||
2003-11-10 | 2003-09-30 | 0.11 | 0.16 | 0.05 | 45 |
ModivCare Corporate Management
| Jack Sawyer | Chief Ingeus | Profile | |
| Mia Haney | Chief Segment | Profile | |
| CFA CFA | Associate Relations | Profile | |
| Jessica Kral | Chief Officer | Profile | |
| Robert Pittman | Senior Affairs | Profile | |
| Chris Heine | Senior NEMT | Profile | |
| Kenneth Shepard | Chief Mobility | Profile |
Additional Tools for ModivCare Stock Analysis
When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.